Back to state act
Description
On 3 March 2021, the Norwegian Medicines Agency introduced an export ban on on all remaining types of immunoglobulins not already on the list. This did not impact the following types of immunoglobulin...
Sign in to see full description
Intervention Details
Intervention Type
Export ban
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
03 Mar 2021
Revocation date
24 Mar 2021
Implementation level
National
Affected flow
Outward
Announced as temporary
Yes
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 4 products
Threads
See all
This intervention is not part of any Thread yet.